Jump to Main Content
Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma
- Abdelmoneem, Mona A., Mahmoud, Mazen, Zaky, Amira, Helmy, Maged W., Sallam, Marwa, Fang, Jia-You, Elkhodairy, Kadria A., Elzoghby, Ahmed O.
- Journal of controlled release 2018 v.287 pp. 78-93
- angiogenesis, apoptosis, berberine, casein, crosslinking, cytotoxicity, deoxycholic acid, encapsulation, folic acid, hepatoma, herbal medicines, histopathology, human cell lines, hydrophobicity, image analysis, immunohistochemistry, mice, micelles, nanomedicine, necrosis, phytopharmaceuticals, phytotherapy, spray drying, staining, transcription factor NF-kappa B, tumor necrosis factor-alpha, water solubility
- In recent years, green nanomedicines have made transformative difference in cancer therapy researches. Herein, we propose dual-functionalized spray-dried casein micelles (CAS-MCs) for combined delivery of two phytochemicals; berberine (BRB) and diosmin (DSN) as targeted therapy of hepatocellular carcinoma (HCC). The nanomicelles enabled parenteral delivery of the poorly soluble DSN via its encapsulation within their hydrophobic core. Moreover, sustained release of the water soluble BRB was attained by hydrophobic ion pairing with sodium deoxycholate followed by genipin crosslinking of CAS-MCs. Dual-active targeting of MCs, via conjugating both lactobionic acid (LA) and folic acid (FA), resulted in superior cytotoxicity and higher cellular uptake against HepG2 cells compared to single-targeted and non-targeted CAS-MCs. The dual-targeted DSN/BRB-loaded CAS-MCs demonstrated superior in vivo anti-tumor efficacy in HCC bearing mice as revealed by down regulation of cell necrosis markers (NF-κB and TNF-α), inflammatory marker COX2, inhibition of angiogenesis and induction of apoptosis. Histopathological analysis and immunohistochemical Ki67 staining confirmed the superiority of the dual-targeted micelles. Ex-vivo imaging showed preferential liver-specific accumulation of dual-targeted CAS-MCs. Overall, this approach combined the benefits of traditional herbal medicine with nanotechnology via LA/FA-CAS-MCs loaded with BRB and DSN as a promising nanoplatform for targeted HCC therapy.